Crossref
SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction
Current Opinion in Physiology · 2026-11 · 101010
DOI: 10.1016/j.cophys.2026.101010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Opinion in Physiology, 2026-11. Verfasst von Joao Carlos Ribeiro-Silva. Die Arbeit nennt 74 Literaturangaben. Gefördert von: American Heart Association Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- American Heart Association Inc
Zitieren
APA
Ribeiro-Silva, J. C. (2026). SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction. Current Opinion in Physiology, 101010. https://doi.org/10.1016/j.cophys.2026.101010
Vancouver
Ribeiro-Silva JC. SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction. Current Opinion in Physiology. 2026:101010. doi:10.1016/j.cophys.2026.101010
BibTeX
@article{RibeiroSilva2026,
author = {Ribeiro-Silva, Joao Carlos},
title = {SGLT2 Inhibitors in Vascular Protection: Modulating Tonic VEGF Signaling and Preventing Rarefaction},
journal = {Current Opinion in Physiology},
year = {2026},
pages = {101010},
doi = {10.1016/j.cophys.2026.101010}
}
EUVIMED